| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.0028 | 1 |